Skip to main content
Clinical Trials/NCT05942833
NCT05942833RecruitingNot Applicable

DATE Trial: Outcomes and Quality of Life in Patients With Early Versus Elective Resection in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis

Kepler University Hospital8 sites in 2 countries136 target enrollmentStarted: January 16, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
136
Locations
8
Primary Endpoint
Gastrointestinal Quality of Life Index

Study Overview

Brief Summary

Patients presenting in hospital with symptoms of acute diverticulitis. Acute inflammation of the left-sided colon is confirmed with CT scan or ultrasound in experienced centers and diagnosis is defined according to the "Classification of Diverticular Disease (CDD)". CDD Type 2a, 2b and 3b will be included and then randomized in two groups. Group A will get an early left hemicolectomy 7 to 10 days after admission and initial antibiotic therapy and/or drainage of the abscess. Group B is designated for an elective resection 6 to 8 weeks after dismissal at the earliest and initial conservative treatment and/or after drainage of the abscess. Six weeks after the operation patients of Group A will be asked for their present quality of life with a standardized scoring system (Gastrointestinal Quality of Life Index = GIQLI; Short-form 36 Score = SF-36 Score; Low anterior resection syndrome = LARS Score). Group B (elective resection) will be asked at their readmission prior to elective surgery is done. This survey package will be repeated again 6 to 8 weeks later in both groups. Primary endpoints will be the two GIQLI at the said examination times. Secondary endpoints will be SF-36 score, LARS-score, GIQLI-Domains, anastomosis insufficiency and other complications, mortality and length of hospital stay. Comparisons between the groups are made at the said examination times but also 6-8 weeks after the operation.

Detailed Description

Primary endpoints:

Gastrointestinal Quality of Life Index (GIQLI)

Secondary endpoints:

SF-36 score (physical and mental health summary scores), LARS score, GIQLI-domains, anastomosis insufficiency and other complications, exitus and length of hospital stay

Treatment strategy:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Informed consent to participate in the study
  • CDD Type 2a, 2b: acute complicated left-sided diverticulitis
  • CDD Type 3b: relapsing diverticulitis without complications (>2 episodes within 2 years)
  • Acute presentation
  • Inflammation located in the left-sided colon
  • Inflammation is CT proven or ultrasound confirmed from experienced radiologists

Exclusion Criteria

  • < 18 years
  • Pregnancy
  • BMI > 55kg/m2
  • Current colorectal carcinoma in the left-sided colon
  • Oral and/or intravenous corticosteroid
  • Ongoing chemotherapy
  • Status post left hemicolectomy
  • Patients who cannot take care of themselves at home or are unable to follow instructions
  • Patients who are not fit for surgery (anesthesia, expert knowledge from specialists) and will not benefit from surgery

Arms & Interventions

Group A (Early)

Experimental

Early left hemicolectomy immediately up to a maximum of 2 days after 7-10 days lasting initial conservative or interventional treatment (e.g: antibiotics, analgesics, drainage) and CT scan/ultrasound proven left-sided colonic diverticulitis

Intervention: Sigmoid resection (Procedure)

Group B (Late)

Other

Elective left hemicolectomy 6 to 8 weeks after 7-10 days lasting initial conservative or interventional treatment (e.g: antibiotics, analgesics, drainage) and CT scan/ultrasound proven left-sided colonic diverticulitis

Intervention: Sigmoid resection (Procedure)

Outcomes

Primary Outcomes

Gastrointestinal Quality of Life Index

Time Frame: Up to 18 weeks

Quality of Life

Secondary Outcomes

  • SF-36 score (Short form score)(Up to 18 weeks)
  • Low anterior resection syndrome score(Up to 18 weeks)
  • Anastomosis insufficiency(Up to 18 weeks)
  • Exitus(Up to 18 weeks)
  • Length of stay (sum of days in hospital until end of study)(Up to 18 weeks)
  • Earlier readmission due to recurrence while waiting for surgery(Up to 18 weeks)
  • Postoperative complication(Up to 18 weeks)
  • Intraoperative complication(Up to 18 weeks)

Investigators

Sponsor
Kepler University Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials